Memorial Sloan Kettering Nassau is a clinical research site located in New York, New York, United States 10065.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
Memorial Sloan Kettering Nassau has participated in 16 clinical trials.
Therapeutic areas: Small Cell Lung Carcinoma, Platinum-sensitive Ovarian Cancer, Second-line, Third-line, or Fourth-line, Carcinoma, Non-small Cell Lung.
Sponsors: Bristol-Myers Squibb.
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Memorial Sloan Kettering Nassau has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Memorial Sloan Kettering Nassau has 16 clinical trials on record. Their work covers Small Cell Lung Carcinoma, Platinum-sensitive Ovarian Cancer, Second-line, Third-line, or Fourth-line, Carcinoma, Non-small Cell Lung.
Yes — Memorial Sloan Kettering Nassau holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.